162 related articles for article (PubMed ID: 36151025)
1. A qualitative exploration of patient preferences for Medicare Part D consultation services offered in a community pharmacy setting.
Murry LT; Witry MJ; Urmie JM
J Am Pharm Assoc (2003); 2023; 63(1):97-107.e3. PubMed ID: 36151025
[TBL] [Abstract][Full Text] [Related]
2. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
[TBL] [Abstract][Full Text] [Related]
3. Using journey mapping to understand the patient experience with selecting a Medicare part D plan using a pharmacy consultation service.
Murry LT; Al-Khatib A; Witry MJ
Explor Res Clin Soc Pharm; 2021 Mar; 1():100006. PubMed ID: 35479501
[TBL] [Abstract][Full Text] [Related]
4. A pharmacy-based referral program to assist low-income Medicare beneficiaries.
Hastings TJ; Hohmann LA; Neal J; Westrick SC
J Am Pharm Assoc (2003); 2019; 59(3):416-422. PubMed ID: 30826302
[TBL] [Abstract][Full Text] [Related]
5. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.
Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME
Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124
[TBL] [Abstract][Full Text] [Related]
6. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
Bono JD; Crawford SY
Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
[TBL] [Abstract][Full Text] [Related]
7. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
9. Patient Medication Adherence Among Pharmacies Participating in a North Carolina Enhanced Services Network.
Urick BY; Bhosle M; Farley JF
J Manag Care Spec Pharm; 2020 Jun; 26(6):718-722. PubMed ID: 32463769
[TBL] [Abstract][Full Text] [Related]
10. Community Pharmacy Medicare Part D Consultations: Plan-Switching Decisions and Chronic Medication Adherence.
Murry LT; Murry RC; Deng H; Viyyuri B; Gerleman BL; Urmie J
J Pharm Pract; 2021 Oct; 34(5):727-733. PubMed ID: 32067566
[TBL] [Abstract][Full Text] [Related]
11. Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment.
Porteous T; Ryan M; Bond C; Watson M; Watson V
PLoS One; 2016; 11(3):e0152257. PubMed ID: 27031588
[TBL] [Abstract][Full Text] [Related]
12. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand.
Hansen RA; Roth MT; Brouwer ES; Herndon S; Christensen DB
J Am Pharm Assoc (2003); 2006; 46(6):700-6. PubMed ID: 17176685
[TBL] [Abstract][Full Text] [Related]
13. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the service quality of community pharmacies for non-prescription medicines based on the perspectives of pharmacists and patients: a qualitative study.
Wongvedvanij R; Darawong C
J Commun Healthc; 2023 Mar; 16(1):38-45. PubMed ID: 36919811
[TBL] [Abstract][Full Text] [Related]
16. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
[TBL] [Abstract][Full Text] [Related]
17. Attitudes of Medicare-eligible Americans toward mail service pharmacy.
Rupp MT
J Manag Care Pharm; 2013 Sep; 19(7):564-72. PubMed ID: 23964618
[TBL] [Abstract][Full Text] [Related]
18. Use of pharmacists or pharmacies as Medicare Part D information sources.
Kennelty KA; Thorpe JM; Chewning B; Mott DA
J Am Pharm Assoc (2003); 2012; 52(6):e205-9. PubMed ID: 23229982
[TBL] [Abstract][Full Text] [Related]
19. Pharmacists' experience of a diabetes risk-assessment service and analytical quality control in community pharmacies - A focus-group study.
Risøy AJ; Skeide Kjome RL; Svensberg K; Råheim M; Sølvik UØ
Res Social Adm Pharm; 2021 Jul; 17(7):1259-1266. PubMed ID: 34155978
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare Beneficiaries.
Berenbrok LA; Gabriel N; Coley KC; Hernandez I
JAMA Netw Open; 2020 Jul; 3(7):e209132. PubMed ID: 32667653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
